Related Experiment Video
Updated: Jun 11, 2026

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
IRX2 Negatively Regulates IRF3-Mediated Type I Interferon and Antiviral Response
Linxu Wang1,2, Yunjie Zou2,3, Yongkang Zhang2,3
1School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation, Yantai University, Yantai, China.
None:
While type I interferon is critical for viral clearance in host defense, its production needs to be tightly regulated in both physiological and infectious contexts. Herein, we reported that an Iroquois homeobox protein IRX2 negatively regulates the activation of type I interferon signaling during influenza infection. We found that IRX2 binds to the IRF3 and negatively regulates IRF3 activation and IRF3-mediated interferon signaling. Knockdown of IRX2 upregulated the phosphorylation of IRF3 and augmented the production of type I interferon cytokines and antiviral immunity. We further showed that genetic abrogation of IRX2 protected mice from lethal influenza infection. Our results reveal a previously unrecognized non-transcriptional function of IRX2, and suggest a potential therapeutic target in viral infections.
More Related Videos
Related Concept Videos
Regulation of the Unfolded Protein Response
Inhibitors of Viral Protein Synthesis
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

